Read more in our blog about the latest NAFLD research

The Latest Research for NAFLD!

November 29, 2021 | By | Clinical Research, NAFLD | Blog, Clinical trials, Fatty Liver Disease, liver health

In the medical world, we are always trying to find new ways to treat all kinds of conditions. Non-alcoholic fatty liver disease, or NAFLD, is a condition that we are constantly learning more about, especially in the work of clinical …

Hepatic Encephalopathy

Hepatic Encephalopathy

October 27, 2021 | By | Fibroscan, Hepatic Encephalopathy | Blog, Clinical research, Clinical trials, HE

Hepatic encephalopathy (HE) can develop when your liver can no longer remove toxic substances from your blood. The toxins build up and can travel through your body until they eventually reach your brain. This causes mental and physical symptoms of …

Catch Cirrhosis from The Start

Catch Cirrhosis from The Start

September 29, 2021 | By | Cirrhosis, Fibroscan | Blog, Clinical trials, NAFLD, NASH

Cirrhosis of the liver is a progressive disease, developing slowly over many years. If allowed to continue, the buildup of scar tissue can eventually stop liver function. Because of the gradual decline, liver cirrhosis often goes undetected and unnoticed. You …

Hispanic adults may be at risk

Liver Disease and the Hispanic Population

July 13, 2021 | By | Clinical Trials, Liver Disease | Blog, Clinical trials, NAFLD, NASH

The number of U.S. adults with non-alcoholic fatty liver disease (NAFLD) currently sits around 25%. Approximately 2-3% of them will go on to develop non-alcoholic steatohepatitis (NASH). NASH is a more severe form of NAFLD and can lead to fibrosis, …